Key Highlights
- Lam Research (LRCX) achieved a record peak of $274.42, marking a 262% increase year-over-year
- Third-quarter fiscal earnings exceeded projections; fourth-quarter outlook surpassed market expectations
- TD Cowen elevated its target price to $340 from $290, reaffirming Buy recommendation
- Major firms including UBS, Stifel, RBC, Cantor Fitzgerald, and TD Cowen maintain bullish positions
- Management confirmed the firm has already achieved its 2028 calendar year financial objectives ahead of schedule
Shares of Lam Research (LRCX) climbed to an unprecedented peak of $274.42 during Thursday’s trading session, marking the culmination of an extraordinary year that saw the semiconductor equipment manufacturer’s stock appreciate by over 262%.
Lam Research Corporation, LRCX
Data from InvestingPro reveals the company’s twelve-month performance delivered a 267% return, with shares currently hovering less than 1% beneath their 52-week pinnacle of $273.50.
The remarkable upward trajectory has been fueled by impressive financial performance and a wave of positive analyst revisions throughout recent weeks.
Lam delivered third-quarter fiscal results that exceeded both Stifel’s projections and broader market consensus. Additionally, the semiconductor equipment maker provided fourth-quarter guidance demonstrating revenue expansion and margin improvements beyond analyst expectations.
Executive leadership highlighted that the organization has already achieved its targeted financial framework for calendar year 2028 and subsequent periods — well in advance of the original timeline.
Wall Street Elevates Price Projections
On Wednesday, TD Cowen analyst Krish Sankar increased his price objective for LRCX to $340 from $290 while maintaining a Buy recommendation. Sankar recognized that skeptics may emphasize constrained upside potential following the robust June quarter guidance and premium valuation multiples, yet maintained that customer demand strength and enhanced profitability justify additional estimate revisions.
Stifel similarly preserved its Buy stance while boosting its target to $325, highlighting the company’s impressive quarterly performance.
RBC Capital elevated its objective to $310, emphasizing robust demand driven by generative artificial intelligence applications and market share expansion, coupled with an enhanced forecast for wafer fabrication equipment expenditure in 2026.
Cantor Fitzgerald maintained its Overweight designation with a $320 price target, noting an improved wafer fabrication equipment landscape extending through 2026 and 2027.
UBS reaffirmed its Buy recommendation, emphasizing Lam’s evolution into what analysts characterize as an AI-powered expansion phase.
Strong Fundamentals Support Rally
Lam’s underlying financial metrics have remained robust throughout the stock’s appreciation. The organization boasts an exemplary Piotroski Score of 9, indicating exceptional financial health, while 20 analysts have increased their earnings projections in recent periods, per InvestingPro data.
TD Cowen’s Sankar acknowledged that critics will point to elevated valuation multiples following the strong guidance, but the firm maintains that customer demand dynamics and profitability trends remain constructive.
LRCX concluded Thursday’s session with approximately 4% gains, positioning the stock adjacent to its newly established record high of $274.42.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
